Connection

WILLIAM PEACOCK to Length of Stay

This is a "connection" page, showing publications WILLIAM PEACOCK has written about Length of Stay.
Connection Strength

1.811
  1. Is Rivaroxaban Associated With Shorter Hospital Stays and Reduced Costs Versus Parenteral Bridging to Warfarin Among Patients With Pulmonary Embolism? Clin Appl Thromb Hemost. 2017 Oct; 23(7):830-837.
    View in: PubMed
    Score: 0.335
  2. Influence of the length of hospitalisation in post-discharge outcomes in patients with acute heart failure: Results of the LOHRCA study. Eur J Intern Med. 2019 Dec; 70:24-32.
    View in: PubMed
    Score: 0.104
  3. Reducing the hospital burden associated with the treatment of pulmonary embolism. J Thromb Haemost. 2019 05; 17(5):720-736.
    View in: PubMed
    Score: 0.101
  4. The effect of a short-stay unit on hospital admission and length of stay in acute heart failure: REDUCE-AHF study. Eur J Intern Med. 2017 May; 40:30-36.
    View in: PubMed
    Score: 0.087
  5. Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation status. Int J Clin Pract. 2017 Jan; 71(1).
    View in: PubMed
    Score: 0.086
  6. Outcomes associated with observation stays versus inpatient admissions for pulmonary embolism. J Thromb Thrombolysis. 2016 Nov; 42(4):513-9.
    View in: PubMed
    Score: 0.085
  7. Hospital length-of-stay and costs among pulmonary embolism patients treated with rivaroxaban versus parenteral bridging to warfarin. Intern Emerg Med. 2017 Apr; 12(3):311-318.
    View in: PubMed
    Score: 0.085
  8. Outcomes related to variation in hospital pulmonary embolus observation stay utilization. Hosp Pract (1995). 2016 Aug; 44(3):133-7.
    View in: PubMed
    Score: 0.083
  9. Change to costs and lengths of stay in the emergency department and the Brisbane protocol: an observational study. BMJ Open. 2016 Feb 25; 6(2):e009746.
    View in: PubMed
    Score: 0.081
  10. Short-term mortality risk in emergency department acute heart failure. Acad Emerg Med. 2011 Sep; 18(9):947-58.
    View in: PubMed
    Score: 0.060
  11. Primary role of B-type natriuretic peptide across the clinical spectrum: from emergency medicine to transitional care and beyond into the community. Congest Heart Fail. 2011 Jan-Feb; 17(1):8-13.
    View in: PubMed
    Score: 0.057
  12. Impact of intravenous loop diuretics on outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE registry. Cardiology. 2009; 113(1):12-9.
    View in: PubMed
    Score: 0.049
  13. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008 May 15; 358(20):2117-26.
    View in: PubMed
    Score: 0.047
  14. Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis. Emerg Med J. 2008 Apr; 25(4):205-9.
    View in: PubMed
    Score: 0.047
  15. Prolonged emergency department stays of non-ST-segment-elevation myocardial infarction patients are associated with worse adherence to the American College of Cardiology/American Heart Association guidelines for management and increased adverse events. Ann Emerg Med. 2007 Nov; 50(5):489-96.
    View in: PubMed
    Score: 0.045
  16. Impact of early initiation of intravenous therapy for acute decompensated heart failure on outcomes in ADHERE. Cardiology. 2007; 107(1):44-51.
    View in: PubMed
    Score: 0.041
  17. Protocol for Improving Care by FAster risk-STratification through use of high sensitivity point-of-care troponin in patients presenting with possible acute coronary syndrome in the EmeRgency department (ICare-FASTER): a stepped-wedge cluster randomised quality improvement initiative. BMJ Open. 2024 06 13; 14(6):e083752.
    View in: PubMed
    Score: 0.036
  18. Acute Emergency Department management of heart failure. Heart Fail Rev. 2003 Oct; 8(4):335-8.
    View in: PubMed
    Score: 0.034
  19. Clinical and economic impact of nesiritide. Am J Health Syst Pharm. 2003 Aug 15; 60 Suppl 4:S21-6.
    View in: PubMed
    Score: 0.034
  20. Rapid optimization: strategies for optimal care of decompensated congestive heart-failure patients in the emergency department. Rev Cardiovasc Med. 2002; 3 Suppl 4:S41-8.
    View in: PubMed
    Score: 0.030
  21. Prehospital electrocardiograms (ECGs) do not improve the process of emergency department care in hospitals with higher usage of ECGs in non-ST-segment elevation myocardial infarction patients. Clin Cardiol. 2009 Dec; 32(12):668-75.
    View in: PubMed
    Score: 0.026
  22. The value of sPESI for risk stratification in patients with pulmonary embolism. J Thromb Thrombolysis. 2019 Jul; 48(1):149-157.
    View in: PubMed
    Score: 0.026
  23. ICare-ACS (Improving Care Processes for Patients With Suspected Acute Coronary Syndrome): A Study of Cross-System Implementation of a National Clinical Pathway. Circulation. 2018 01 23; 137(4):354-363.
    View in: PubMed
    Score: 0.023
  24. Benefit of early discharge among patients with low-risk pulmonary embolism. PLoS One. 2017; 12(10):e0185022.
    View in: PubMed
    Score: 0.023
  25. Improved Assessment of Chest pain Trial (IMPACT): assessing patients with possible acute coronary syndromes. Med J Aust. 2017 Aug 04; 207(5):195-200.
    View in: PubMed
    Score: 0.022
  26. Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies. Curr Med Res Opin. 2017 09; 33(9):1697-1703.
    View in: PubMed
    Score: 0.022
  27. Morphine Use in the ED and Outcomes of Patients With Acute Heart Failure: A Propensity Score-Matching Analysis Based on the EAHFE Registry. Chest. 2017 10; 152(4):821-832.
    View in: PubMed
    Score: 0.022
  28. External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications. BMC Health Serv Res. 2016 10 22; 16(1):610.
    View in: PubMed
    Score: 0.021
  29. Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism. Pharmacotherapy. 2016 10; 36(10):1109-1115.
    View in: PubMed
    Score: 0.021
  30. A 2-hour diagnostic protocol for possible cardiac chest pain in the emergency department: a randomized clinical trial. JAMA Intern Med. 2014 Jan; 174(1):51-8.
    View in: PubMed
    Score: 0.018
  31. Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes. JAMA. 2009 Nov 25; 302(20):2207-13.
    View in: PubMed
    Score: 0.013
  32. Low-risk acute heart failure patients: external validation of the Society of Chest Pain Center's recommendations. Crit Pathw Cardiol. 2009 Sep; 8(3):99-103.
    View in: PubMed
    Score: 0.013
  33. Venous thromboembolism prophylaxis in hospitalized heart failure patients. J Card Fail. 2008 Mar; 14(2):127-32.
    View in: PubMed
    Score: 0.012
  34. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am J Cardiol. 2008 Jan 15; 101(2):231-7.
    View in: PubMed
    Score: 0.011
  35. ED patients with heart failure: identification of an observational unit-appropriate cohort. Am J Emerg Med. 2006 May; 24(3):319-24.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.